Concord Drugs (BOM:538965) Other Long Term Assets : ₹0.0 Mil (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Concord Drugs Other Long Term Assets?

Concord Drugs's other long-term assets for the quarter that ended in Dec. 2023 was ₹0.0 Mil.

Concord Drugs's quarterly other long-term assets increased from Jun. 2023 (₹0.0 Mil) to Sep. 2023 (₹15.5 Mil) but then stayed the same from Sep. 2023 (₹15.5 Mil) to Dec. 2023 (₹0.0 Mil).

Concord Drugs's annual other long-term assets increased from Mar. 2021 (₹6.7 Mil) to Mar. 2022 (₹7.7 Mil) and increased from Mar. 2022 (₹7.7 Mil) to Mar. 2023 (₹16.4 Mil).

Concord Drugs Other Long Term Assets Historical Data

The historical data trend for Concord Drugs's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Concord Drugs Other Long Term Assets Chart

Concord Drugs Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Other Long Term Assets

Get a 7-Day Free Trial

16.79

17.15

6.66

7.71

16.37

Concord Drugs Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Long Term Assets	Get a 7-Day Free Trial															-	16.37	-	15.47	-

Concord Drugs Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Concord Drugs (BOM:538965) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Concord Drugs Ltd (BOM:538965) » Definitions » Other Long Term Assets

Traded in Other Exchanges

N/A

Address

3-11-451, L B Nagar, Hayatnagar Mandal, Hyderabad, TG, IND, 500074

Website

https://www.concorddrugs.in

Concord Drugs Ltd is an India based pharmaceutical company. The principal activity of the company is to manufacture licensed drugs based on the formulations approved. Its product portfolio includes Pharmaceutical Ready to fill Pellets, MUPS ((Multiple Unit Pellets System); Tissue Bio Adhesive; Injectables (Small Volume Parenterals); Capsules; Liquid Orals (Syrups & Suspensions); Dry Syrups (Powder) and Hand Sanitizers. Geographically, it operates only in India.

Concord Drugs (BOM:538965) Headlines

No Headlines